Organization
Taiho Pharmaceutical
6 clinical trials
Clinical trial
A Phase 1 Study of TAS-116 (Pimitespib) in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal TumorStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Dose Escalating Study of TAS3731 in Healthy AdultsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Platform Study of AB122 Based Treatments in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
A Phase 2a, Randomized, Double-blind, Study of TAS5315 in Chronic Spontaneous Urticaria Patients With an Inadequate Response to H1-antihistaminesStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Phase 3, Randomized, Placebo-controlled, Double-blind and Open-label, Extension Study of TAS-205 in Patients With Duchenne Muscular DystrophyStatus: Recruiting, Estimated PCD: 2027-05-01
Clinical trial
A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male SubjectsStatus: Completed, Estimated PCD: 2022-11-03